Zur Rose Group AG, a Swiss pharmaceutical distributor, operates through two divisions: Zur Rose, which focuses on wholesale medicine supply to healthcare providers, and DocMorris, which manages mail-order pharmacy sales. The company has a presence in Switzerland, Germany, and the Netherlands, with several subsidiaries including Zur Rose Suisse AG and DocMorris NV. UBS has maintained a sell rating on the company.